What Is CJC-1295 with DAC?
A Long-Acting Growth-Hormone-Releasing Hormone Analog Under Study in Endocrine Biology
CJC-1295 with DAC is a synthetic peptide related to growth-hormone-releasing hormone, or GHRH - the signaling molecule that helps regulate growth-hormone release from the pituitary gland.
It has attracted scientific interest because researchers have studied GHRH analogs in relation to pituitary signaling, growth-hormone release, and the broader growth-hormone/IGF-1 axis. Human research on CJC-1295 with DAC remains limited. It is not FDA-approved to diagnose, treat, cure, or prevent any disease or medical condition.
Have questions about peptide therapy? Call Advanced Mobile IV to speak with our team.
What Researchers Are Studying
-
The GHRH Pathway
Growth-hormone-releasing hormone is produced in the brain and signals the pituitary gland to release growth hormone. Researchers study GHRH analogs to better understand this normal endocrine signaling pathway.
-
Pituitary Signaling
CJC-1295 with DAC is being studied for its interaction with receptors involved in pituitary growth-hormone signaling. Growth hormone itself is one of the measurements researchers may examine in this type of research.
-
The Growth-Hormone/IGF-1 Axis
Scientists also study the broader relationship among GHRH, growth hormone, and insulin-like growth factor 1, or IGF-1. This is a complex regulatory system, and changes in one part of the pathway do not establish a particular clinical outcome.
Quick Answer
CJC-1295 with DAC is a modified GHRH analog. It is not growth hormone itself. Rather, researchers study it for its interaction with the GHRH pathway involved in pituitary growth-hormone signaling. "DAC" refers to a drug-affinity complex designed to extend the peptide's time in circulation compared with formulations without DAC.
At a Glance
What it is
A synthetic peptide related to growth-hormone-releasing hormone.
Why it attracts attention
Researchers study it in connection with pituitary signaling and the growth-hormone/IGF-1 axis.
What the evidence looks like
Research on GHRH analogs exists, but human evidence remains limited and important questions are unanswered.
Important context
CJC-1295 with DAC is an investigational peptide and is not FDA-approved for any medical indication.
What We Know - and What Remains Unclear
CJC-1295 with DAC is often discussed in peptide communities because of its relationship to the GHRH pathway and its longer-acting design. But a biological mechanism is not the same as a proven health outcome.
Important questions remain about its safety, effectiveness, appropriate use, and long-term effects in humans. Anyone considering peptide therapy should have an individualized conversation with a qualified provider who can discuss current evidence, limitations, health history, medications, and other relevant considerations.
Wellness, Delivered With Care
"Getting IV fluids when I was feeling ill was so beneficial to my healing. I'm grateful for AMIV and the service they provide. I would recommend everyone try this."
Jeff Weaver
Customer
"Very professional. The owners explained this treatment in detail. The procedure I received helped with fatigue and dehydration. I enjoyed the relaxed atmosphere of being in my own home."
Jennifer Belch
Customer
"I have had multiple experiences with Advance Mobile IV and all have been AMAZING! Painless pokes and incredible results, make me feel 100 times better. So thankful I found this company."
Cortlin Beck
Customer
Frequently Asked Questions
Is CJC-1295 with DAC the same as growth hormone?
No. CJC-1295 with DAC is not growth hormone. It is a peptide related to growth-hormone-releasing hormone, which is involved in signaling between the brain and pituitary gland.
What does "DAC" mean?
"DAC" refers to a drug-affinity complex used to extend the time certain CJC-1295 formulations remain in circulation.
Is CJC-1295 with DAC the same as CJC-1295 No DAC?
They are related but distinct formulations. The DAC designation refers to the addition of a drug-affinity complex designed to create a longer-acting formulation.
Is CJC-1295 with DAC FDA-approved?
No. CJC-1295 with DAC is not FDA-approved to diagnose, treat, cure, or prevent any disease or medical condition.
Learn More About Peptide Therapy
Emerging peptide science is complicated. Advanced Mobile IV can help you understand the current conversation around CJC-1295 with DAC and other peptide therapies, the questions to ask, and whether a discussion with a qualified provider makes sense for you.
Call Advanced Mobile IV to Learn MoreThis page is for educational purposes only and is not medical advice. CJC-1295 with DAC is an investigational peptide; research is ongoing, and scientific understanding continues to evolve.
AMIV Wellness Hub
Recent Blog Posts
Mobile IV
Jan 08, 2026
